MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
The New England Journal of Medicine Downloaded from nejm.org at UC SHARED JOURNAL COLLECTION on April 17, 2015. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2010 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UC SHARED JOURNAL COLLECTION on April 17, 2015. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2010 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UC SHARED JOURNAL COLLECTION on April 17, 2015. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2010 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UC SHARED JOURNAL COLLECTION on April 17, 2015. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2010 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UC SHARED JOURNAL COLLECTION on April 17, 2015. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2010 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UC SHARED JOURNAL COLLECTION on April 17, 2015. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2010 Massachusetts Medical Society. All rights reserved.
Suggest Documents
The respiratory microbiome in idiopathic pulmonary fibrosis.
Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis.
Quantitative analysis of pathogens in the lower respiratory tract of patients with chronic obstructive pulmonary disease.
Staging of acute exacerbation in patients with idiopathic pulmonary fibrosis.
Clinical use of nintedanib in patients with idiopathic pulmonary fibrosis.
Intrapulmonary concentration of levofloxacin in patients with idiopathic pulmonary fibrosis.
Prognosis of idiopathic pulmonary fibrosis in patients with mucous hypersecretion.
Bone mineral density in patients with idiopathic pulmonary fibrosis.
Eosinophil alveolitis in two patients with idiopathic pulmonary fibrosis.
Clinical characteristics in patients with asymmetric idiopathic pulmonary fibrosis.
Physical activity in patients with idiopathic pulmonary fibrosis.
Lung cancer in patients with idiopathic pulmonary fibrosis.
Estimating Lifetime Asbestos Exposure in Patients With Idiopathic Pulmonary Fibrosis.
End-of-life care of patients with idiopathic pulmonary fibrosis.
Perceptions, experiences and needs of patients with idiopathic pulmonary fibrosis.
The psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review.
Moving stem cell therapy to patients with idiopathic pulmonary fibrosis.
[Idiopathic Pulmonary Fibrosis].
Idiopathic pulmonary fibrosis.
Idiopathic progressive pulmonary fibrosis.
Reflux in idiopathic pulmonary fibrosis.
Epigenetics in idiopathic pulmonary fibrosis.
Rhinoscleroma of the lower respiratory tract.
Localized amyloidosis of the lower respiratory tract.
Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis.
The New England Journal of Medicine Downloaded from nejm.org at UC SHARED JOURNAL COLLECTION on April 17, 2015. For personal use only. No other uses w...
3MB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
The respiratory microbiome in idiopathic pulmonary fibrosis.
Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis.
Quantitative analysis of pathogens in the lower respiratory tract of patients with chronic obstructive pulmonary disease.
Staging of acute exacerbation in patients with idiopathic pulmonary fibrosis.
Clinical use of nintedanib in patients with idiopathic pulmonary fibrosis.
Intrapulmonary concentration of levofloxacin in patients with idiopathic pulmonary fibrosis.
Prognosis of idiopathic pulmonary fibrosis in patients with mucous hypersecretion.
Bone mineral density in patients with idiopathic pulmonary fibrosis.
Eosinophil alveolitis in two patients with idiopathic pulmonary fibrosis.
Clinical characteristics in patients with asymmetric idiopathic pulmonary fibrosis.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms